95 related articles for article (PubMed ID: 11270999)
1. Pharmacokinetics of sustained-release capsule of 5-isosorbide mononitrate in 20 healthy Chinese young men.
Luo WX; Zhang YD; Shen JP; Ding Y; Huang DK; Luo JP; Qiu J; Jiang ZH; Peng JH; Sheng LS
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):951-6. PubMed ID: 11270999
[TBL] [Abstract][Full Text] [Related]
2. Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations.
Vree TB; Dammers E; Valducci R
Int J Clin Pharmacol Ther; 2004 Aug; 42(8):463-72. PubMed ID: 15366327
[TBL] [Abstract][Full Text] [Related]
3. Single and multiple dose pharmacokinetic studies of oral sustained release and non-sustained release formulations of isosorbide-5-mononitrate in healthy volunteers.
Zhang Q; Huang X; Ji P; Fu L; Yan B; Wei S
Arzneimittelforschung; 1998 Jun; 48(6):641-5. PubMed ID: 9689420
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic profile and bioavailability of a new pharmaceutical formulation of isosorbide-5-mononitrate sustained-release formulation].
Skutta T; Böttcher B; Brandt L
Arzneimittelforschung; 1989 Apr; 39(4):507-11. PubMed ID: 2751738
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of three organic nitrates in Chinese healthy male volunteers.
Chen J; Jiang XG; Cai L; Lu W; Gao KP; Shi ZQ; Zhang QZ
Arzneimittelforschung; 2004; 54(4):203-6. PubMed ID: 15146932
[TBL] [Abstract][Full Text] [Related]
6. [Bioavailability of sustained-release and nonsustained-release isosorbide-5-mononitrate].
Muck B; Bonn R; Rietbrock N
Arzneimittelforschung; 1989 Oct; 39(10):1274-6. PubMed ID: 2610720
[TBL] [Abstract][Full Text] [Related]
7. [Multiple dose pharmacokinetic and bioavailability studies of oral sustained release and conventional formulations of isosorbide-5-mononitrate in healthy volunteers].
Zhang Q; Huang X; Ji P; Fu L; Yan B; Wei S
Yao Xue Xue Bao; 1998 May; 33(5):373-8. PubMed ID: 12017006
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the bioequivalence and pharmacokinetics of two tablet formulations of isosorbide-5-mononitrate after single oral administration in healthy volunteers.
Niopas I; Daftsios AC; Nikolaidis N
Arzneimittelforschung; 2002; 52(3):182-6. PubMed ID: 11963645
[TBL] [Abstract][Full Text] [Related]
9. Relative bioavailability of two isosorbide dinitrate sublingual tablet formulations administered as single doses in healthy subjects.
Niopas I; Daftsios AC; Nikolaidis N
Int J Clin Pharmacol Ther; 2001 May; 39(5):224-8. PubMed ID: 11380069
[TBL] [Abstract][Full Text] [Related]
10. Influence of diet on the single-dose pharmacokinetics of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate.
Sata H; Inoue K; Nii T; Kuroda T
Biol Pharm Bull; 1997 Oct; 20(10):1111-5. PubMed ID: 9353575
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteers.
Hutt V; Bonn R; Fritschi E; Jaeger H
Arzneimittelforschung; 1995 Feb; 45(2):142-5. PubMed ID: 7710435
[TBL] [Abstract][Full Text] [Related]
12. [Determination of isosorbide-5-mononitrate in plasma by GC-ECD and study on its pharmacokinetics in ten volunteers].
Yang LL; Yuan YS; Zhao FL
Yao Xue Xue Bao; 1997 Oct; 32(10):773-6. PubMed ID: 11596222
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.
Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB
Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524
[TBL] [Abstract][Full Text] [Related]
14. [Study of the bioequivalence of a new isosorbide dinitrate tablet formulation compared with the standard preparation].
Metzner JE; Buchberger D; Häring N; Läuter J
Arzneimittelforschung; 1997 Jun; 47(6):719-26. PubMed ID: 9281301
[TBL] [Abstract][Full Text] [Related]
15. [The evaluation of the bioavailability of isosorbide 5-mononitrate].
Dyderski S; Szkutnik D; Drobnik L; Szymańska-Shawkat E
Pol Merkur Lekarski; 1999 Aug; 7(38):64-6. PubMed ID: 10522420
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
[TBL] [Abstract][Full Text] [Related]
17. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of delayed-action and non-delayed-action preparations of isosorbide-5-nitrate].
Heidemann R; Gracien E; Menke G; Rietbrock N
Dtsch Med Wochenschr; 1987 May; 112(18):719-22. PubMed ID: 3569063
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects.
Jin C; Jeon JY; Im YJ; Jeong JA; Kim Y; Chae SW; Bentz J; Kumke T; Kim MG
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):97-106. PubMed ID: 25492848
[TBL] [Abstract][Full Text] [Related]
20. [Bioavailability and bioequivalence of organic nitrates. Isosorbide dinitrate--a study of sustained-release preparations].
Scheidel B; Blume H; Stenzhorn G; Siewert M; Babej-Dölle RM
Arzneimittelforschung; 1991 Mar; 41(3):212-8. PubMed ID: 1867657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]